Task: Answer the multiple-choice question.
Query: Which drug exhibits a -2.987% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
[a] CCN(C(=O)c1cc2c(=O)n3ccccc3nc2s1)C1CCCCC1
[b] O=C(COc1ccccc1)NCc1ccc2c(c1)OCO2
[c] CCOC(=O)c1sc(-c2ccc(C(F)(F)F)cc2)nc1O
Answer: a. CCN(C(=O)c1cc2c(=O)n3ccccc3nc2s1)C1CCCCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN(C(=O)c1cc2c(=O)n3ccccc3nc2s1)C1CCCCC1
CCN(C(=O)c1cc2c(=O)n3ccccc3nc2s1)C1CCCCC1
N-cyclohexyl-N-ethyl-2-oxo-6-thia-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),4,8,10,12-pentaene-5-carboxamide